<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="31953">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02131818</url>
  </required_header>
  <id_info>
    <org_study_id>SI-OBG-CEU-01-2014</org_study_id>
    <nct_id>NCT02131818</nct_id>
  </id_info>
  <brief_title>Necessity of Antibiotics for Prevention of Delivery-associated Infections After Spontaneous Vaginal Delivery at Term</brief_title>
  <official_title>Necessity of Antibiotics for Prevention of Delivery-associated Infections After Spontaneous Vaginal Delivery at Term</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <authority>Thailand: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine amoxicillin is effective in the prevention of
      wound infection in normal labor.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      When the pregnant women is admitted due to  first stage of labor , the investigator will
      inform the patients. If the patients give consent, the patient's data will be collect in
      case record form. the patients will be swab at posterior fornix and around anus to collect
      specimen and send to microbiology lab before per vaginal examination. After the patients
      finish in labor, perineal wound will be swab to collect specimen and send to microbiology
      lab. Then the patients are randomized in two group, the first one will receive amoxicillin
      and the second one will receive placebo. During admission the patients will be exam by
      investigator every day. After the patients are discharge, the follow up will be appoint on 6
      weeks later. The infant will be swab at rectum to collect specimen and send to microbiology
      lab when the patient's discharge day. Every specimen will be culture for bacteria and
      perform antimicrobial susceptibility test for amoxicillin.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">November 2015</completion_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Incidence of perineal wound infection</measure>
    <time_frame>within 6 weeks after normal labor</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Follow up perineal wound every day during admission and follow up 6 weeks after discharge</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1600</enrollment>
  <condition>Perineal Wound Infection</condition>
  <arm_group>
    <arm_group_label>Amoxicillin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patient will be received amoxicillin 500 mg  2 capsules orally bid pc for 5 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The patient will be received placebo  2 capsules orally bid pc for 5 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Amoxicillin</intervention_name>
    <description>The patient will be received amoxicillin 500 mg  2 capsules orally bid pc for 5 days</description>
    <arm_group_label>Amoxicillin</arm_group_label>
    <other_name>Drug A</other_name>
    <other_name>Drug B</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>The patient will be received placebo  2 capsules orally bid pc for 5 days</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Drug A</other_name>
    <other_name>Drug B</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Term pregnancy

          -  Normal labor

        Exclusion Criteria:

          -  Penicillin allergy

          -  Previous history antibiotic using within 2 weeks

          -  Patients cannot take oral medication

          -  Patients have underlying disease eg. diabetes mellitus, hypertension, HIV infection

          -  Premature rupture of membranes
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vitaya Titapant, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Obstetrics &amp; Gynaecology, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vitaya Titapant, MD</last_name>
    <phone>+66816851907</phone>
    <email>vitaya.tit@mahidol.ac.th</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pornpimol Ruangvutilert, MD</last_name>
    <phone>+66819170809</phone>
    <email>sipr@mahidol.ac.th</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Faculty of Medicine Siriraj Hoapital Mahidol University</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vitaya Titapant, MD</last_name>
      <phone>+66816851907</phone>
      <email>vitaya.tit@mahidol.ac.th</email>
    </contact>
    <contact_backup>
      <last_name>Pornpimol Ruangvutilert, MD</last_name>
      <phone>+66819170809</phone>
      <email>sipr@mahidol.ac.th</email>
    </contact_backup>
    <investigator>
      <last_name>Vitaya Titapant, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 4, 2014</lastchanged_date>
  <firstreceived_date>April 28, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>amoxicillin</keyword>
  <keyword>postpartum infections</keyword>
  <keyword>puerperal infection</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Wound Infection</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Amoxicillin</mesh_term>
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
